First In Man Study To Evaluate Initial Safety clinical trials

First In Man Study To Evaluate Initial Safety in Toronto First In Man Study To Evaluate Initial Safety in Vancouver First In Man Study To Evaluate Initial Safety in Montreal First In Man Study To Evaluate Initial Safety in Calgary First In Man Study To Evaluate Initial Safety in Edmonton First In Man Study To Evaluate Initial Safety in Ottawa First In Man Study To Evaluate Initial Safety in Winnipeg First In Man Study To Evaluate Initial Safety in Quebec City First In Man Study To Evaluate Initial Safety in Hamilton First In Man Study To Evaluate Initial Safety in Kitchener First In Man Study To Evaluate Initial Safety in London First In Man Study To Evaluate Initial Safety in Halifax First In Man Study To Evaluate Initial Safety in New York First In Man Study To Evaluate Initial Safety in Los Angeles First In Man Study To Evaluate Initial Safety in Chicago First In Man Study To Evaluate Initial Safety in Houston

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease